InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,068.86
(
1.16%
)
US TECH 100
17,001.60
(
1.49%
)
Dow Jones
38,500.78
(
0.68%
)
Brent Oil
87.23
(
0.94%
)
Bitcoin
66,687.93
(
-0.25%
)
Post# of 63665
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Penny Roger$

Send PM Follow Ignore
Followers 1106
Posts 279775
Boards Moderated 10
Alias Born 03/18/2011

Penny Roger$

Re: None

Saturday, 12/20/2014 5:14:17 PM

Saturday, December 20, 2014 5:14:17 PM

Post# of 63665
Advaxis Announces FDA Acceptance of Its Investigational New Drug Application to Commence Clinical Trials of ADXS-HPV in Combination With MedImmune's MEDI4736 for the Treatment of HPV-Associated Cancers
| 6:30 AM |

[GlobeNewswire] - PRINCETON, N.J. -- Advaxis, Inc. , a clinical-stage biotechnology company developing cancer immunotherapies, announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational ...

http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/advaxis-announces-fda-acceptance-investigational-123000628.html

~ Market News! ~

This news update brought to you by StockGoodies SizzlingStockPicks PennyStockTweets WallStreetSurfers and PennyStockMobsters.
Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html
http://www.stockgoodies.com/chart-school.html


St. Jude 2014 >> http://tinyurl.com/St-Jude-2014
http://www.fallenheroesfund.org/ ~

Do your DD! Spend only the money you can afford to lose, while still willing to play at other tables. Commissions are cheaper than losses!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up